Wells Fargo Remains a Hold on Colgate-Palmolive (CL)

Wells Fargo analyst Christopher Carey maintained a Hold rating on Colgate-Palmolive today and set a price target of $92.00.

Easter Sale - 70% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Carey covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Clorox, and Colgate-Palmolive. According to TipRanks, Carey has an average return of 1.4% and a 47.70% success rate on recommended stocks.

In addition to Wells Fargo, Colgate-Palmolive also received a Hold from TD Cowen’s Robert Moskow in a report issued on April 2. However, yesterday, UBS assigned a Buy rating to Colgate-Palmolive (NYSE: CL).

Based on Colgate-Palmolive’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $5.23 billion and a GAAP net loss of $37 million. In comparison, last year the company earned a revenue of $4.94 billion and had a net profit of $739 million

Based on the recent corporate insider activity of 62 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CL in relation to earlier this year. Most recently, in February 2026, Noel Wallace, the COB, Pres & CEO of CL sold 45,568.00 shares for a total of $4,279,290.88.